Vaccine Weekly

Advanced Life Sciences Holdings, Inc. - Advanced Life Sciences' Restanza Shows 100% Survival in Tularemia Pivotal Animal Study

AIDS Vaccine Advocacy Coalition - AVAC Says MDP 301 Microbicide Trial Results Disappointing, but Researchers and 9,400 Trial Volunteers Deserve Praise for Successful Trial

AVAX Technologies, Inc. - AVAX Technologies, Inc. Closes Bridge Financing

Cellonis Biotechnologies - For the First Time, a Glioma A¨C Brain Cancer A¨C may be Eliminated by a Chinese Research/Medical Team, Using a Novel Stem Cell Based Therapy of Cellonis Biotech, Beijing

CVS Caremark - CVS/pharmacy and MinuteClinic Providing H1N1 Vaccines in 20 States and Washington, D.C.

Duane Reade - Duane Reade Announces Plans for H1N1 Immunization Program

Duke University Medical Center - Biological catch-22 prevents induction of antibodies that block HIV

Emergent BioSolutions Inc. - HHS Cancels RFP for rPA Procurement and Modifies Their Approach in Favor of BAA for Development of rPA Vaccines

Flu Vaccines - Pennsylvania Department of Health Continues to Provide H1N1 Flu Vaccine to Certified Private Providers

Fred Hutchinson Cancer Research Center - M. Elizabeth Halloran Named AAAS Fellow

Geron Corporation - Geron Presents Interim Clinical Data on Its Telomerase Vaccine at the 2009 American Society of Hematology Meeting

Geron Corporation - U.S. Patent Office Grants Geron's Request for an Interference With U.S. Patent No. 7,510,876 to Novocell

Hard to Treat Diseases - Hard to Treat Diseases HTDS Confirms the first Chilean order of 200,000 doses

ImmunoCellular Therapeutics, Ltd. - ImmunoCellular Therapeutics Announces Key Additions to Scientific Advisory Board

Macomb County Health Department - Make a New Year's Resolution for You and Your Family: Get Your H1N1 Flu Vaccine

Merck Serono - Merck KGaA Starts Stimuvax Phase III Study INSPIRE in Asian Patients with Advanced NSCLC

Pall Corporation - Pall Corporation Reports First Quarter Results

Pennsylvania Department of Health - Department of Health Urges Expanded H1N1 Vaccination Efforts to Include All Patients

Pfenex Inc. - Pfenex Grants Exclusive License to Merck & Co., Inc. for the Production of Proteins for Undisclosed Vaccine Program

Pfizer Inc. - Pfizer Inc. Affirms Confidence In Its Hormone Therapy Medicines As Important Treatment Options

Pfizer Inc. - Pfizer Receives European Authorization for Prevenar 13* for the Prevention of Pneumococcal Disease In Infants and Young Children

Research and Markets - Freeze Drying Equipment - a Global Market Perspective

Sanofi Pasteur - Sanofi Pasteur Expands Study of Vaccine Against Clostridium difficile into the U.S.

Sanofi Pasteur - Sanofi Pasteur Obtains License from Syntiron to Develop & Commercialize Vaccine to Prevent Staphylococcus Infections

SRI International - SRI International Receives U.S. Patent for Needle-Free Transmucosal Drug Delivery System

Uppsala University - Major breakthrough may pave the way for therapeutic vaccines

Walgreens - Walgreens to Offer H1N1 Vaccine at More Than 30 Chicago Locations Beginning Dec. 11, Partnering with City Department of Public Health on Inoculation Effort